EHE underperformed the Australian Healthcare industry which returned -4.8% over the past year. Interest Coverage: EHE is unprofitable, therefore interest payments are not well covered by earnings. Find out more at Intelligent Investor 1 Year Return. Mr. Thorley was the Chief Operating Officer of Esti... Show more. than the rest of Australian stocks over the past 3 months. (-19.2%), as it is currently unprofitable. EHE is trading below fair value by more than 20%. FT is not responsible for any use of content by you outside its scope as stated in the. Explore potentially undervalued companies in the Healthcare industry. Join the HotCopper ASX share market forum today for free. Tuesday 23 February 2021 commencing at 9.30am (AEDT) Estia Health Limited (ASX: EHE) (Estia or Company) advises that it will announce its FY21 Half Year results for the period ending 31 December 2020 on Tuesday 23 February 2021.Shareholders and guests will be able to pre-register by clicking here. Explore strong dividend paying companies in the Healthcare industry. 20/11/2020 18:55:07 1-888-992-3836 Free Membership Login Health & Biotech. Share price information may be rounded up/down and therefore not entirely accurate. Latest Share Price and Events Stable Share Price : EHE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. Explore growth companies in the Healthcare industry. Where can I find the current share price? Growing Profit Margin: EHE is currently unprofitable. 337927). Find out more at Intelligent Investor EHE has a dividend yield higher than 75% … Future Dividend Coverage: No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market. Explore more healthy companies in the Healthcare industry. All content on FT.com is for your general information and use only and is not intended to address your particular requirements. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. He joined Estia Health in October 2016. have bought more shares than they have sold in the past 3 months. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. Estia Health Limited operates residential aged care homes in Australia. Future ROE: EHE's Return on Equity is forecast to be low in 3 years time (4.4%). Australia and Victoria. Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares? This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. As of June 30, 2020, it had 69 homes, which include 6,182 resident places in New South Wales, Queensland, South Australia, and Victor... Show more. All markets data located on FT.com is subject to the. EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the. Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. Notable Dividend: Unable to evaluate EHE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. Long Term Liabilities: EHE's short term assets (A$50.6M) do not cover its long term liabilities (A$301.3M). Unless specified all financial data is based on a yearly period but updated quarterly. Data delayed at least 20 minutes, as of Jan 15 2021 05:10 GMT. According to a note out of Morgan Stanley, its analysts have downgraded this aged care operator’s shares to an underweight rating with a reduced price target of $1.50. Collapsed. Earnings vs Savings Rate: EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). Return vs Market: EHE underperformed the Australian Market which returned -1.6% over the past year. Estia Health (ASX:EHE) ... EHE Share Price and Trading History. PE vs Industry: EHE is unprofitable, so we can't compare its PE Ratio to the AU Healthcare industry average. 3. Estia Health Ltd (ASX: EHE) Share Price and News. Return vs Industry: EHE underperformed the Australian Healthcare industry which returned -4.8% over the past year. View Estia Health Limited ASX:EHE share price history, dividends & company information on SharePrices.com.au View Estia Health Limited ASX:EHE share price history, dividends & company information on SharePrices.com.au Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. Join the HotCopper ASX share market forum today for free. Unable to compare EHE's earnings growth over the past year to its 5-year average as it is currently unprofitable. The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has edged 1.9% lower today following the release of its Q1 results. Quality Earnings: EHE is currently unprofitable. Debt Level: EHE's debt to equity ratio (21.4%) is considered satisfactory. EHE's debt to equity ratio has increased from 10% to 21.4% over the past 5 years. Rise and Shine: What you need to know before the ASX opens In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriberâs or othersâ use of S&P Capital IQ. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. ALL RIGHTS RESERVED. What Kind Of Shareholders Hold The Majority In Estia Health Limited's (ASX:EHE) Shares? Estia Health Limited's company bio, employee growth, exchange listings and data sources, Estia Health Limited operates residential aged care homes in Australia. EHE underperformed the Australian Market which returned -1.6% over the past year. All else being equal, a share price drop should make a stock more attractive to potential investors. Unable to evaluate EHE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. Earnings vs Industry: EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.1%). Insider Buying: EHE insiders have bought more shares than they have sold in the past 3 months. Any information that you receive via FT.com is at best delayed intraday data and not "real time". Estia Health's P/E tells us that market participants think it will not fare as well as its peers in the same industry. Mr. Thorley was the Chief Operating Officer of Esti. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. ASX:EHE Price Estimation Relative to Market, March 19th 2020. One share of EHE stock can currently be purchased for approximately A$1.735. Experienced Management: EHE's management team is considered experienced (2.8 years average tenure). Growing Dividend: Insufficient data to determine if EHE's dividend payments have been increasing. News. Estia Health Limited (EHE) Overview. Is Estia Health (ASX:EHE) Using Too Much Debt? High Dividend: Unable to evaluate EHE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. ASX jumps on hope for COVID-19 drug remdesivir, ... Shares in Estia Health have dropped by 3.3 per cent to $1.45, ... driving up their share prices to record high levels. Short Term Liabilities: EHE's short term assets (A$50.6M) do not cover its short term liabilities (A$960.3M). EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). HotCopper has news, discussion, prices and market data on ESTIA HEALTH LIMITED. Estia Health Limited operates residential aged care homes in Australia. Estia Health's mailing address is Level 9, 227 Elizabeth Street, SYDNEY, NSW, AUSTRALIA, 2000. Ian's compensation has been consistent with company performance over the past year. Shares in Estia Health are currently priced at A$1.75. EHE's short term assets (A$50.6M) do not cover its. Who are the major shareholders and have insiders been buying or selling? Estia Health Limited (EHE) Announcements. Unable to evaluate EHE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. EHE is not paying a notable dividend for the Australian market. At that level they are trading at 2.4% premium to the analyst consensus target price of 0.00. It has 68 operational homes and 6,046 operational places for residents with over 7,000 employed staff. The Estia Health Ltd (ASX: EHE) share price is tumbling lower today as the aged care provider officially gets cut from the S&P/ASX 200 Index. Learn more here. Debt Coverage: EHE's debt is well covered by operating cash flow (96.9%). Experienced Board: EHE's board of directors are considered experienced (3.7 years average tenure). In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. Its clinical care services include regular reviews and includes daily medication; pain management programs; medical services, such physiotherapy, pharmacy, podiatry, optometry and dental; specialist dementia care and personal care. RELATED STOCKHEAD STORIES. EHE:ASX price moved over -1.12% to 1.77 Dec 24 2020 Key statistics As of last trade Estia Health Ltd (EHE:ASX) traded at 1.83, -30.15% below its 52-week high of 2.62, set on Jan 23, 2020. The Clinuvel (ASX:CUV) share price edges down on Q1 update. Long term investing works well, but it doesn't always work for each individual stock. High Growth Earnings: EHE's is expected to become profitable in the next 3 years. The Financial and Risk business of Thomson Reuters is now. Check Estia Health Limited (ASX:EHE) Share Price, Stock News, Stock Chart, Trends, Market Data, Announcements and Unique Analysis on Kalkine Media Mon, January 11, 2021 Australia Edition Reducing Debt: EHE's debt to equity ratio has increased from 10% to 21.4% over the past 5 years. Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. is forecast to be low in 3 years time (4.4%). You must be a registered user to save alerts. Collapsed. PE vs Market: EHE is unprofitable, so we can't compare its PE Ratio to the Australian market. Explore strong past performing companies in the Healthcare industry. Estia Health (EHE) share price, charts, trades & the UK's most popular discussion forums. Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. Insufficient data to determine if EHE's dividends per share have been stable in the past. EHE's is expected to become profitable in the next 3 years. View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer … Estia Health Ltd. Investors saw the billion-dollar company’s shares sink by more than 8% in early trading. EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. Analysts covering Estia Health currently have a consensus Earnings Per Share (EPS) forecast of 0.058 for the next financial year. Below Fair Value: EHE (A$1.71) is trading below our estimate of fair value (A$4.65). Estia Health trades on ASX (Australian Stock Exchange) under the ticker symbol "EHE". $1.77. EHE is unprofitable, so we can't compare its, EHE is unprofitable, so we can't compare its. Estia Health's (ASX:EHE) Shareholders Are Down 78% On Their Shares. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. 2. Compensation vs Market: Ian's total compensation ($USD585.53K) is about average for companies of similar size in the Australian market ($USD711.61K). Estia Health Limited operates residential aged care homes in Australia. No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market. It offers various general activities, such as gardening, reading, movies, music, parties, cultural celebrations, art sessions or daytrips, lifestyle coordinators can also cater for specialist interests. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. Insufficient data to determine if EHE's dividend payments have been increasing. Collapsed. Volatility Over Time: EHE's weekly volatility (9%) has been stable over the past year. 0.025 (-1.39%) 52 Week Range. How has Estia Health's share price performed over time and what events caused price changes? No risks detected for EHE from our risk checks. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Is Estia Health undervalued compared to its fair value and its price relative to the market? Dilution of Shares: Shareholders have not been meaningfully diluted in the past year. He joined Estia Health in October 2016. Aged care provider Estia Health Ltd suffered a weak start in today’s trading on the ASX. Read More » S&P/ASX 200 To Open Lower, 3 ASX Shares To Watch Estia Health Limited () Stock Market info Recommendations: Buy or sell Estia Health stock? EHE Share Price - Get the latest Estia Health (EHE) share price ASX and detailed information including EHE Share Chart, EHE Share Technical Analysis and Financials / Fundamental Data. ASX Announcements and Latest News from ESTIA HEALTH LIMITED. Fair value with moderate growth potential. Please read our Financial Services Guide before deciding whether to obtain financial services from us. High Growth Revenue: EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. Revenue vs Market: EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). All rights reserved. Its clinical care services include regular reviews and includes daily medication; pain management programs; medical services, such physiotherapy, pharmacy, podiatry, optometry and dental; specialist dementia care and personal care. $0.905 - $2.62. How is Estia Health's financial position? How is Estia Health forecast to perform in the next 1 to 3 years based on estimates from 6 analysts? Markit Short Selling Activity © Markit. The Estia Health Ltd (ASX:EHE) share price is down close to 4% in reaction to the company’s half year result to December 2018. Estia Health Limited (EHE.AX) (ASX:EHE) Dividend Information Estia Health Limited (EHE.AX) pays an annual dividend of A$0.13 per share, with a dividend yield of ∞. PB vs Industry: EHE is good value based on its PB Ratio (0.7x) compared to the AU Healthcare industry average (1.8x). Estia Health Ltd (ASX: EHE) Price. How can I contact Estia Health? Earnings Trend: EHE is unprofitable, and losses have increased over the past 5 years at a rate of 13.5% per year. It provides services across approximately 69 homes in New South Wales, Queensland, South. Read More » Formed in October 2013, Estia Health Limited (ASX:EHE) is one of the leading providers of residential aged care in Australia operating 6,182 resident places across 69 homes in New South Wales, Queensland, South Australia and Victoria. EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.1%).
Clear Sinking Fly Line,
Zombie Skittles 2020,
Delphi Language Example,
Coffee Flavored Rum Brands,
Chicken Parm Sandwich On Ciabatta,
Best Buy Complaints Forum,
Schneider Electric North America Headquarters Address,
Nfu Mutual's Home Insurance,